Professional Documents
Culture Documents
SHIFTING: 2
TRANS #: 5
-Len-
c.
the risk of death from a particular disease, may diminish signs and symptoms, or prevent recurrence of the disease example: randomized trial among breast cancer patients that compared radical mastectomy with more limited resection
Types of experimental study according to allocation of treatment 1. Clinical Trials a. Allocation to individuals b. Ex. Effectiveness of a Drug A vs. Drug B in the treatment of hypertension; randomized trial among breast cancer patients that compared radical mastectomy with more limited resection; field trial of the poliomyelitis vaccine among healthy children Community Trials a. Allocation to group of individuals or communities b. Less expensive than large scale clinical trials c. Ex. Water fluoridation experiment
most powerful design in being able to elucidate possible cause and effect relationship done to resolve issues about the beneficial effect of a treatment that are generated from the observational study provides data on the harmful effects of the treatment as well
2.
Advantages the investigator is the one who assigns the subjects to the exposure or treatment groups the allocation of treatment is done randomly Disadvantages 1. Ethical issues a. treatment should not be withheld to the subject b. harmful experiments should not be done Feasibility a. Others want to be on the treatment's side than control, sometimes not feasible More costly than observational studies
Reference or Control Population The population to which one would like to generalize the results of the experimental study Ex. Males and females above 40 years for an experimental study on the effects of aspirin on cardiovascular mortality Experimental or Intervention Population The population that is actually studied SCHEMA
2.
(+) Outcome Expt'l group Eligible subjects Control group (+) Outcome
3.
(-) Outcome
Types of experimental studies according to type of exposure 1. Prophylactic Trials a. Involve the evaluation of whether a treatment or procedure reduces the risk of developing disease b. Conducted among healthy individuals who are considered at risk of dose c. example: field trial of the poliomyelitis vaccine among healthy children 2. Therapeutic Trials a. Conducted among patients with particular disease b. Done to see whether a certain treatment or procedure may reduce
Considerations in the choice of an experimental population 1. should be sufficiently large 2. should experience a sufficient number of endpoints or outcomes within the study group
noahkajirelly
DATE: 19July2011 Page 1 of 2
3.
obtaining complete and accurate follow up information from the participants is feasible
intervention is not effective to bring about change Solve for sample size n= 2 (Z + Z)2 S2 d2 Where: n = sample size Z = z deviate corresponding to the error Z = z deviate corresponding to the error S2 = variance d = difference to be detected
Allocation of Treatment 1. Randomization a. Procedure for assigning treatments to individuals in such a way that all possible assignments of treatments to individuals are equally likely b. advantages: i. eliminates selection bias ii. with sufficiently large sample size, the different groups tend to be more comparable in terms of known and unknown factors iii. gives validity to the statistical treatment of data 2. Blocking a. Individuals with the same characteristics that affect the outcome are first grouped into blocks before treatment is allocated to the individuals in a block b. In community trials, randomization may not be necessary Maintaining and Assessment of Compliance Strategies: 1. selection of populations who are both interested and reliable 2. frequent contact with participants 3. use of incentives 4. use of calendar packs of study population Measurement of compliance levels: 1. Self reports 2. Pill counts on the returned (unused) pills 3. Laboratory determinations Ascertainment of Outcome Strategies: 1. Blinding a. Single blind observer b. Double blind subject and observer c. Triple blind subject, observer and data analyst 2. Use of more objective definition of outcome 3. Use of same procedure for diagnosis Interpretation of Results In community trials, if there are changes in the risk factor levels and no changes in the disease rates, these may be explained by: 1. No association between the risk factor and the disease 2. Changes in the risk factor levels were not large enough to effect changes in disease rate 3. Risk factor changes should have been identified earlier in life to produce changes 4. The risk factor changes should be sustained for longer periods to be effective In community trials, absence of many changes in the levels of the risk factors may mean either the intervention package is not effective or the efforts in the implementation of the
Page 2 of 2